1. Alterations in bile acid synthesis in carriers of hepatocyte nuclear factor 1α mutations. (6th May 2013) Authors: Ekholm, E.; Nilsson, R.; Groop, L.; Pramfalk, C. Journal: Journal of internal medicine Issue: Volume 274:Number 3(2013:Sep.) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cholesterol trapping by SOAT1 induces mitochondrial cholesterol accumulation and decrease oxidative metabolism. (August 2022) Authors: Da Dalt, L.; Pedrelli, M.; Pramfalk, C.; Norata, G.D.; Parini, P. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice. Issue 7 (July 2019) Authors: Ahmed, O.; Pramfalk, C.; Pedrelli, M.; Olin, M.; Steffensen, K.R.; Eriksson, M.; Parini, P. Journal: Digestive and liver disease Issue: Volume 51:Issue 7(2019) Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Genetic depletion of the Soat2 gene diminishes diet-induced hepatic steatosis and improves glucose tolerance in mice. (August 2018) Authors: Pramfalk, C.; Ahmed, O.; Larsson, L.; Härdfeldt, J.; Pedrelli, M.; Vedin, L.; Steffensen, K.; Tellez, M.; Delbes, A.; Denis, R.; Luquet, S.; Eriksson, M.; Parini, P. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19. (August 2021) Authors: Ahmed, O.; Mukarram, A.K.; Pirazzini, C.; Marasco, E. Elena; Pedrelli, M.; Minniti, M.E.; Gustafsson, U.; Pramfalk, C.; Binder, C.J.; Petrillo, E.; Garagnani, P. Paolo; Daub, C.O.; Eriksson, M.; Parini, P. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Remnant cholesterol reduction by ezetimibe and simvastatin does not affect biliary lipid concentration in gallstone patients. (September 2016) Authors: Eriksson, M.; Ahmed, O.; Gustafsson, U.; Littman, K.; Sahlin, S.; Pramfalk, C.; Parini, P. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Simvastatin and ezetimibe reduce plasma lipoprotein binding to human arterial proteoglycans in gallstone diseased patients. (August 2018) Authors: Littmann, K.; Ahmed, O.; Gustafsson, U.; Pramfalk, C.; Öörni, K.; Larsson, L.; Sahlin, S.; Camejo, G.; Parini, P.; Eriksson, M. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Soat2 depletion improves insulin sensitivity and hepatic steatosis. (September 2016) Authors: Parini, P.; Pramfalk, C.; Ahmed, O.; Larsson, L.; Karpe, F.; Neville, M.; Eriksson, M. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Validation of network medicine interactomes: From patients to a human hepatocyte-like model. (August 2022) Authors: Grassi, F.; Dall'Olio, D.; Ahmed, O.; Sala, C.; Bersanelli, M.; Pramfalk, C.; Garagnani, P.; Petrillo, E.; Loscalzo, J.; Pedrelli, M.; Parini, P. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗